Whatever the reason behind the confusion stirred up by Mr. Curtis Hill in the November of 2017, it seems we can finally put it in the back burner. People who were using this as a health regiment for various ailments (especially the epileptic ones) shall continue to use it as a remedy. It is because there is no need to worry about any law restricting it.
Another concern is about medications with which CBD might interact. This won’t be an issue with most drugs, says Sunil Kumar Aggarwal, M.D., Ph.D., a palliative medicine physician and scientist who studies cannabis and integrates it into his Seattle medical practice. The exceptions are blood thinners, IV antibiotics, and other drugs whose exact dosing is crucial and must be monitored closely, he says. (Of course, if you have a health problem, talk to your doctor before using CBD, and never take it instead of seeing your physician for a serious condition.)
Great pain relief, better than several other products we’ve tried. Aloe Vera, Arnica and Tea Tree are great additional ingredients but PLEAS GET RID OF THE FD&C Blue 1FC & Yellow 10 (food dye), Methylparaben & Alcohol. You took a great product and ruined it with these ingredients that have negative effects on our health (dye & paraben) or just smell bad and have a drying effect on the skin (alcohol). Please go back to the lab and improve the formulation to make this truly a great product that I’d continue to use and highly recommend to all.
Disclaimer: The Federal Food, Drug, and Cosmetic Act require this disclaimer. We collected this information from various sources for the convenience of our customers. The statements made regarding these products were not evaluated by the Food and Drug Administration. The efficacy of these products is not confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure, or prevent any disease. The information presented here is not meant as a substitute for information from health care practitioners. It is also not meant as an alternative to information from health care practitioners. Before using any product, you should consult your doctor and ask about the risk of interactions or complications.
The legal problems occur once the extracts contain higher percentages of THC, or when they’re made from cannabis plants that are no longer considered “hemp” (so basically high THC plants). Products with these extracts might be in violation of the United States Controlled Substances Act (US CSA). This is when laws regarding specific states or countries will apply.
In the United States, non-FDA approved CBD products are classified as Schedule I drugs under the Controlled Substances Act. This means that production, distribution, and possession of non-FDA approved CBD products is illegal under federal law. In addition, in 2016 the Drug Enforcement Administration added "marijuana extracts" to the list of Schedule I drugs, which it defined as "an extract containing one or more cannabinoids that has been derived from any plant of the genus Cannabis, other than the separated resin (whether crude or purified) obtained from the plant." Previously, CBD had simply been considered "marijuana", which is a Schedule I drug.
Sativex® (GW Pharmaceuticals) is an oromucosal whole cannabis-based spray combining a CB1 partial agonist (THC) with a cannabinoid system modulator (CBD), minor cannabinoids and terpenoids plus ethanol and propylene glycol excipients and peppermint flavoring (McPartland and Russo 2001; Russo and Guy 2006). It was approved by Health Canada in June 2005 for prescription for central neuropathic pain in multiple sclerosis, and in August 2007, it was additionally approved for treatment of cancer pain unresponsive to optimized opioid therapy. Sativex is a highly standardized pharmaceutical product derived from two Cannabis sativa chemovars following Good Agricultural Practice (GAP) (de Meijer 2004), yielding Tetranabinex® (predominantly-THC extract) and Nabidiolex® (predominantly-CBD extract) in a 1:1 ratio. Each 100 μL pump-action oromucosal Sativex spray actuation provides 2.7 mg of THC and 2.5 mg of CBD. Pharmacokinetic data are available, and indicate plasma half lives of 85 minutes for THC, 130 minutes for 11-hydroxy-THC and 100 minutes for CBD (Guy and Robson 2003). Sativex effects commence in 15–40 minutes, an interval that permits symptomatic dose titration. A very favorable adverse event profile has been observed in over 2500 patient years of exposure in over 2000 experimental subjects. Patients most often ascertain an individual stable dosage within 7–10 days that provides therapeutic relief without unwanted psychotropic effects (often in the range of 8–10 sprays per day). In all RCTs, Sativex was adjunctively added to optimal drug regimens in subjects with intractable symptoms, those often termed “untreatable.” Sativex is also available by named patient prescription in the UK and the Catalonia region of Spain. An Investigational New Drug (IND) application to study Sativex in advanced clinical trials in the USA was approved by the FDA in January 2006 in patients with intractable cancer pain.
In this edition of Cannabis Conversations, Project CBD Director, Martin A. Lee, discusses the benefits of CBD, the "entourage effect" and the microbiome with Dr. Ethan Russo. A neurologist, scientist, and widely published author, Dr. Russo is currently the director of research and development at the International Cannabis and Cannabinoids Institute in Prague (www.icci.science).
James Joliat, a 35-year-old video producer in Denver, has long experienced muscle and joint pain—mostly related to sports injuries. He says he started looking at natural remedies as an alternative to the prescription patches and pills his doctor recommended. After experimenting with homemade rubs infused with plant compounds—stuff like arnica and turmeric—he eventually stumbled onto topical cannabidiol (CBD) rubs.
Given its name, you might assume THCV shares psychoactive powers with its potent counterpart, THC. In reality, this cannabinoid is more like a cross between CBD and THC. From the former, it takes its modulating powers. Acting like THC “lite,” THCV like CBD can dampen the effects of a strong high. Yet at higher doses, THCV kicks into a psychoactive stimulant in its own right.
And like many new sectors, the cannabis business has already seen its share of shareholder manipulation and self-dealing by executives, as MarketWatch has reported. Just last week, Aphria Inc. said an investigation of acquisitions in Argentina, Colombia and Jamaica found that some directors had conflicts of interest. The company’s CEO Vic Neufeld and co-founder Cole Cacciavillani are leaving their roles in March, although they will stay on as advisers.
Cannabis most likely originates from Central Asia, as archeological evidence indicates that it was already cultivated in China for food and fiber 10 000 years ago. Even in ancient Egyptian mummies, clues have been found for the use of Cannabis as food or medicine.25 In fact, Cannabis is one of the oldest known medicinal plants and is described in almost every ancient handbook on plant medicine, most commonly in the form of a tincture or a tea.26,27 Some religions were closely related with the properties of the Cannabis plant. For example, in Hindu legend, Cannabis is believed to be the favorite food of the god Shiva, because of its energizing properties. As Cannabis spread from Asia toward the West, almost every culture came into contact with this miracle plant. Nowadays, varieties of Cannabis can be found in all temperate and tropical zones, except in humid, tropical rain forests.28
Cannabis, also referred to as marijuana, has been an integral part of human civilizations for millennia. Both as a medicine and as a recreational substance, cannabis is the most popular illicit drug in the world. Today, the legal landscape that has prohibited marijuana for much of the twentieth century is giving way to decriminalization and full legalization. Legal, commercial cannabis businesses are already making an enormous economic impact.
The other 29 states that fully legalize the Medical use of all CBD products derived from either hemp or Marijuana are: Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Hawaii, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Dakota, Ohio, Oregon, Pennsylvania, Rhode Island, Vermont, Washington and West Virginia. The territories of Guam and Puerto Rico also allow the use of CBD products on medical grounds.